| Jul 23 |
3 Russell 2000 Growth Stocks That Could Be Worth the Risk
|
| Jul 15 |
Andreas Halvorsen's Strategic Acquisition in Longboard Pharmaceuticals
|
| Jul 9 |
Wall Street Analysts Think Longboard Pharmaceuticals (LBPH) Could Surge 43.7%: Read This Before Placing a Bet
|
| Jul 9 |
Longboard Pharmaceuticals (LBPH) is on the Move, Here's Why the Trend Could be Sustainable
|
| Jul 3 |
Top 3 Health Care Stocks That May Crash This Quarter
|
| Jul 2 |
Longboard (LBPH) Up 14% as Epilepsy Drug Gets Breakthrough Tag
|
| Jul 1 |
Longboard Pharmaceuticals Receives Breakthrough Therapy Designation for Bexicaserin (LP352)
|
| Jun 10 |
Longboard Pharmaceuticals Announces Positive Interim Results from the Open-Label Extension (OLE) of the Phase 1b/2a PACIFIC Study Evaluating Bexicaserin in Participants with Developmental and Epileptic Encephalopathies (DEEs)
|
